GE HealthCare securities fraud investigation
Analysis based on 6 articles · First reported Jul 08, 2026 · Last updated Jul 24, 2026
GE HealthCare's stock dropped 13.2% after the earnings miss and guidance cut, reflecting investor concern over operational issues. The securities investigation adds legal risk and may further pressure the stock.
Law Offices of Howard G. Smith is investigating GE HealthCare Technologies Inc. for possible violations of federal securities laws. On April 29, 2026, GE HealthCare reported Q1 earnings with adjusted EPS of $0.99 and cut full-year 2026 adjusted EPS guidance to $4.80-$5.00 from $4.95-$5.15, citing a recall associated with a PDx supplier and declines in PCS. The stock fell 13.2% to $59.49. On July 23, 2026, CFO Jay Saccaro announced his departure. The investigation seeks to recover losses for investors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard